Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients
Julia Dorn, Manfred Schmitt, Ronald Kates, et al.
Life (Basel, Switzerland)
|
October 27, 2022
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
Yueyang Liu, Weiwei Gong, Sarah Preis, et al.
Expert Opinion on Therapeutic Targets
|
August 18, 2018
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
Daniela Loessner, Peter Goettig, Sarah Preis, et al.
Journal of Ovarian Research
|
October 22, 2020
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
Weiwei Gong, Yueyang Liu, Eleftherios P Diamandis, et al.
Plos One
|
February 28, 2019
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
Weiwei Gong, Yueyang Liu, Christof Seidl, et al.
Plos One
|
November 3, 2017
Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
Xiaocong Geng, Yueyang Liu, Sandra Diersch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer
Carla A Borgoño, Tadaaki Kishi, Andreas Scorilas, et al.
Biological Chemistry
|
August 19, 2011
mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer
Matthias Kotzsch, Julia Dorn, Kristina Doetzer, et al.
Biological Chemistry
|
August 10, 2006
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
Julia Dorn, Nadia Harbeck, Ronald Kates, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 9, 2004
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis
Eleftherios P Diamandis, Carla A Borgoño, Andreas Scorilas, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients
Julia Dorn, Manfred Schmitt, Ronald Kates, et al.
Life (Basel, Switzerland)
|
October 27, 2022
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
Yueyang Liu, Weiwei Gong, Sarah Preis, et al.
Expert Opinion on Therapeutic Targets
|
August 18, 2018
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
Daniela Loessner, Peter Goettig, Sarah Preis, et al.
Journal of Ovarian Research
|
October 22, 2020
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
Weiwei Gong, Yueyang Liu, Eleftherios P Diamandis, et al.
Plos One
|
February 28, 2019
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
Weiwei Gong, Yueyang Liu, Christof Seidl, et al.
Plos One
|
November 3, 2017
Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
Xiaocong Geng, Yueyang Liu, Sandra Diersch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer
Carla A Borgoño, Tadaaki Kishi, Andreas Scorilas, et al.
Biological Chemistry
|
August 19, 2011
mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer
Matthias Kotzsch, Julia Dorn, Kristina Doetzer, et al.
Biological Chemistry
|
August 10, 2006
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
Julia Dorn, Nadia Harbeck, Ronald Kates, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 9, 2004
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis
Eleftherios P Diamandis, Carla A Borgoño, Andreas Scorilas, et al.
Page
of 6